Tyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic mice

Vascular Pharmacology

Volumn 55, Issue 5-6, 2011, Pages 149-156

  Elmarakby, Ahmed A ^a,b   Ibrahim, Ahmed S ^a,b   Faulkner, Jessica ^a   Mozaffari, Mahmood S ^a   Liou, Gregory I ^a   Abdelsayed, Rafik ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Albuminuria; Diabetes; Gp91phox; ICAM 1; Nephrinuria; P tyrosine

Indexed keywords

ALBUMIN; COLLAGEN; GENISTEIN; GLUCOSE; GLYCOPROTEIN GP 91; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; NEPHRIN; PHOSPHOTYROSINE; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; ENZYME ACTIVATION; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; KIDNEY INJURY; MALE; MOUSE; NEPHRITIS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEINURIA;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; APOPTOSIS; BIOLOGICAL MARKERS; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; GENISTEIN; HUMANS; KIDNEY; MALE; MAP KINASE SIGNALING SYSTEM; MESANGIAL CELLS; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RANDOM ALLOCATION; STREPTOZOCIN;

EID: 84866556074     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2011.07.007     Document Type: Article

References (47)

1. Ae Park S., Choi M.S., Cho S.Y., Seo J.S., Jung U.J., Kim M.J., Sung M.K., Park Y.B., Lee M.K. Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sci. 2006, 79(12):1207-1213.
2. Baluchnejadmojarad T., Roghan M. Chronic administration of genistein improves aortic reactivity of streptozotocin-diabetic rats: mode of action. Vasc. Pharmacol. 2008, 49(1):1-5.
3. Berkow R.L., Dodson R.W. Alterations in tyrosine protein kinase activities upon activation of human neutrophils. J. Leukoc. Biol. 1991, 49(6):599-604.
4. Choi M.S., Jung U.J., Yeo J., Kim M.J., Lee M.K. Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diab./Metab. Res. Rev. 2008, 24(1):74-81.
5. Chow F., Ozols E., Nikolic-Paterson D.J., Atkins R.C., Tesch G.H. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int. 2004, 65:116-128.
6. Correll P.H., Morrison A.C., Lutz M.A. Receptor tyrosine kinases and the regulation of macrophage activation. J. Leukoc. Biol. 2004, 75:731-737.
7. Dong Z., O'Brian C.A., Fidler I.J. Activation of tumoricidal properties in macrophages by lipopolysaccharide requires protein-tyrosine kinase activity. J. Leukoc. Biol. 1993, 53(1):53-60.
8. Elmarakby A.A., Faulkner J., Posey S.P., Sullivan J.C. Induction of hemeoxygenase-1 attenuates the hypertension and renal inflammation in spontaneously hypertensive rats. Pharmacol. Res. 2010, 62(5):400-407.
9. Falk R.J., Scheinman J.I., Mauer S.M., Michael A.F. Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 1983, 32(Suppl 2):34-39.
10. Frey R.S., Singletary K.W. Genistein activates p38 mitogen-activated protein kinase, inactivates ERK1/ERK2 and decreases Cdc25C expression in immortalized human mammary epithelial cells. J. Nutr. 2003, 133(1):226-231.
11. Fu Z., Zhang W., Zhen W., Lum H., Nadler J., Bassaganya-Riera J., Jia Z., Wang Y., Misra H., Liu D. Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice. Endocrinology 2010, 151(7):3026-3037.
12. Furuta T., Saito T., Ootaka T., Soma J., Obara K., Abe K., Yoshinaga K. The role of macrophages in diabetic glomerulosclerosis. Am. J. Kidney Dis. 1993, 21:480-485.
13. Garrington T.P., Johnson G.L. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 1999, 11:211-218.
14. Herrlich P., Bohmer F.D. Redox regulation of signal transduction in mammalian cells. Biochem. Pharmacol. 2000, 59(1):35-41.
15. Ibrahim A.S., El-Shishtawy M.M., Peña A., Liou G.I. Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation. Mol. Vis. 2010, 16:2033-2042.
16. Jeong H.Y., Son S.M., Kim Y.K., Yun M.R., Lee S.M., Kim C.D. Tyrosine kinase-mediated activation of NADPH oxidase enhances proliferative capacity of diabetic vascular smooth muscle cells. Life Sci. 2005, 76(15):1747-1757.
17. Kakizaki Y., Waga S., Sugimoto K., Tanaka H., Nukii K., Takeya M., Yoshimura T., Yokoyama M. Production of monocyte chemoattractant protein-1 by bovine glomerular endothelial cells. Kidney Int. 1995, 48(6):1866-1874.
18. Kato M., Abraham R.T., Kita H. Tyrosine phosphorylation is required for eosinophil degranulation induced by immobilized immunoglobulins. J. Immunol. 1995, 155(1):357-366.
19. Kaul K., Hodgkinson A., Tarr J.M., Kohner E.M., Chibber R. Is inflammation a common retinal-renal-nerve pathogenic link in diabetes?. Curr. Diab. Rev. 2010, 6:294-303.
20. Kim J.M., Lee E.K., Kim D.H., Yu B.P., Chung H.Y. Kaempferol modulates pro-inflammatory NF-kappaB activation by suppressing advanced glycation endproducts-induced NADPH oxidase. Age (Dordr) 2010, 32(2):197-208.
21. Lee J.S. Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocin-induced diabetic rats. Life Sci. 2006, 79(16):1578-1584.
22. Li Y., Wang S. Glycated albumin activates NADPH oxidase in rat mesangial cells through up-regulation of p47phox. Biochem. Biophys. Res. Commun. 2010, 397(1):5-11.
23. Ma W., Yuan L., Yu H., Ding B., Xi Y., Feng J., Xiao R. Genistein as a neuroprotective antioxidant attenuates redox imbalance induced by beta-amyloid peptides 25-35 in PC12 cells. Int. J. Dev. Neurosci. 2010, 28(4):289-295.
24. Mogensen C.E., Schmitz A., Christensen C.K. Comparative renal pathophysiology relevant to IDDM and NIDDM patients. Diab. Metab. Rev. 1988, 4(5):453-483. Review.
25. Nakajima M., Cooney M.J., Tu A.H., Chang K.Y., Cao J., Ando A., An G.J., Melia M., de Juan E. Normalization of retinal vascular permeability in experimental diabetes with genistein. Investig. Ophthalmol. Vis. Sci. 2001, 42(9):2110-2114.
26. Nakajima K., Tohyama Y., Kohsaka S., Kurihara T. Protein kinase C alpha requirement in the activation of p38 mitogen-activated protein kinase, which is linked to the induction of tumor necrosis factor alpha in lipopolysaccharide-stimulated microglia. Neurochem. Int. 2004, 44(4):205-214.
27. Ohashi N., Urushihara M., Satou R., Kobori H. Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen species-ERK/JNK pathways. Hypertens. Res. 2010, 33(11):1174-1181.
28. Page T.H., Smolinska M., Gillespie J., Urbaniak A.M., Foxwell B.M. Tyrosine kinases and inflammatory signalling. Curr. Mol. Med. 2009, 9(1):69-85.
29. Polkowski K., Mazurek A.P. Biological properties of genistein. A review of in vitro and in vivo data. Acta Pol. Pharm. 2000, 57(2):135-155.
30. Ruetten H., Thiemermann C. Effects of tyrphostins and genistein on the circulatory failure and organ dysfunction caused by endotoxin in the rat: a possible role for protein tyrosine kinase. Br. J. Pharmacol. 1997, 122:59-70.
31. Saleh M.A., Boesen E.I., Pollock J.S., Savin V.J., Pollock D.M. Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes. Diabetologia 2010.
32. Sasser J.M., Sullivan J.C., Hobbs J.L., Yamamoto T., Pollock D.M., Carmines P.K., Pollock J.S. Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism. J. Am. Soc. Nephrol. 2007, 18:143-154.
33. Si H., Liu D. Phytochemical genistein in the regulation of vascular function: new insights. Curr. Med. Chem. 2007, 14:2581-2589.
34. Sonee M., Sum T., Wang C., Mukherjee S.K. The soy isoflavone, genistein, protects human cortical neuronal cells from oxidative stress. Neurotoxicology 2004, 25(5):885-891.
35. Stevens V.A., Saad S., Chen X.M., Pollock C.A. The interdependence of EGF-R and SGK-1 in fibronectin expression in primary kidney cortical fibroblast cells. Int. J. Biochem. Cell Biol. 2007, 39:1047-1054.
36. Sung S.H., Ziyadeh F.N., Wang A., Pyagay P.E., Kanwar Y.S., Chen S. Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J. Am. Soc. Nephrol. 2006, 17(11):3093-3104.
37. Sung M.J., Kim D.H., Jung Y.J., Kang K.P., Lee A.S., Lee S., Kim W., Davaatseren M., Hwang J.T., Kim H.J., Kim M.S., Kwon D.Y., Park S.K. Genistein protects the kidney from cisplatin-induced injury. Kidney Int. 2008, 74:1538-1547.
38. Tesch G.H. Macrophages and diabetic nephropathy. Semin. Nephrol. 2010, 30:290-301.
39. Valsecchi A.E., Franchi S., Panerai A.E., Rossi A., Sacerdote P., Colleoni M. The soy isoflavone genistein reverses oxidative and inflammatory state, neuropathic pain, neurotrophic and vasculature deficits in diabetes mouse model. Eur. J. Pharmacol. 2010, 15(650):694-702.
40. Vlahovic G., Crawford J. Activation of tyrosine kinases in cancer. Oncologist 2003, 8(6):531-538.
41. Wada T., Furuichi K., Sakai N., Iwata Y., Yoshimoto K., Shimizu M., Takeda S.I., Takasawa K., Yoshimura M., Kida H., Kobayashi K.I., Mukaida N., Naito T., Matsushima K., Yokoyama H. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int. 2000, 58:1492-1499.
42. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diab. Care 2004, 27:1047-1053.
43. Wong W.S., Koh D.S., Koh A.H., Ting W.L., Wong P.T. Effects of tyrosine kinase inhibitors on antigen challenge of guinea pig lung in vitro. J. Pharmacol. Exp. Ther. 1997, 283(1):131-137.
44. Xu S.Z., Zhong W., Ghavideldarestani M., Saurabh R., Lindow S.W., Atkin S.L. Multiple mechanisms of soy isoflavones against oxidative stress-induced endothelium injury. Free Radic. Biol. Med. 2009, 47(2):167-175.
45. Yang W., Wang S., Li L., Liang Z., Wang L. Genistein reduces hyperglycemia and islet cell loss in a high-dosage manner in rats with alloxan-induced pancreatic damage. Pancreas 2010.
46. Yeh C.H., Sturgis L., Haidacher J., Zhang X.N., Sherwood S.J., Bjercke R.J., Juhasz O., Crow M.T., Tilton R.G., Denner L. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion. Diabetes 2001, 50(6):1495-1504.
47. Yuan W.J., Jia F.Y., Meng J.Z. Effects of genistein on secretion of extracellular matrix components and transforming growth factor beta in high-glucose-cultured rat mesangial cells. J. Artif. Organs 2009, 12(4):242-246.